# NT-proBNP Levels in the Prediction of Intrapartum and Postpartum Events in Adult Congenital Heart Disease Patients

> **NCT04231591** · — · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 34 (actual)

## Conditions studied

- Congenital Heart Disease
- Pregnancy Complications

## Interventions

- **DIAGNOSTIC_TEST:** NT-proBNP

## Key facts

- **NCT ID:** NCT04231591
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-11-13
- **Primary completion:** 2023-12-01
- **Final completion:** 2023-12-01
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2024-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04231591

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04231591, "NT-proBNP Levels in the Prediction of Intrapartum and Postpartum Events in Adult Congenital Heart Disease Patients". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT04231591. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*